Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglaret

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Iscience|February 2, 2026
Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19Rodolphe Thiébaut, Edouard Lhomme, Hakim Hocini, et al.
The Journal of Infectious Diseases|August 14, 2018
Kinetics of Soluble Mediators of the Host Response in Ebola Virus DiseaseRomy Kerber, Ralf Krumkamp, Misa Korva, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|May 16, 2002
[Bacillary angiomatosis in an adult infected with HIV-1 at an early stage of immunodepression in Abidjan, Côte d'Ivoire]K A Minga, I Gberi, M B Boka, et al.
Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4<sup>+</sup> cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.
AIDS Research and Therapy|March 1, 2016
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialCalixte Guehi, Anani Badjé, Delphine Gabillard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2021
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiationDelphine Gabillard, Jean-Baptiste N'Takpé, Marie-Laure Chaix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV ReplicationGérard-Menan Kouamé, Anders Boyd, Raoul Moh, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Iscience|February 2, 2026
Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19Rodolphe Thiébaut, Edouard Lhomme, Hakim Hocini, et al.
The Journal of Infectious Diseases|August 14, 2018
Kinetics of Soluble Mediators of the Host Response in Ebola Virus DiseaseRomy Kerber, Ralf Krumkamp, Misa Korva, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|May 16, 2002
[Bacillary angiomatosis in an adult infected with HIV-1 at an early stage of immunodepression in Abidjan, Côte d'Ivoire]K A Minga, I Gberi, M B Boka, et al.
Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4<sup>+</sup> cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.
AIDS Research and Therapy|March 1, 2016
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialCalixte Guehi, Anani Badjé, Delphine Gabillard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2021
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiationDelphine Gabillard, Jean-Baptiste N'Takpé, Marie-Laure Chaix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV ReplicationGérard-Menan Kouamé, Anders Boyd, Raoul Moh, et al.
Pageof 27